Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.70
Bid: 2.60
Ask: 2.80
Change: 0.00 (0.00%)
Spread: 0.20 (7.692%)
Open: 2.70
High: 2.70
Low: 2.70
Prev. Close: 2.70
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Nyota Minerals, Mariana Resources, Bluestar...

Thu, 17th Jun 2010 08:14

Miner Nyota Minerals said drilling at its flagship Tulu Kapi gold project in Ethiopia has confirmed the presence of a new mineralized structure beneath the inferred resource of 1.38m ounces of gold.Also in gold mining, Mariana Resources said it made an encouraging intersection of gold north of the Belleza prospect in Chile.Chinese digital video surveillance firm BlueStar SecuTech has won a new contract with the Tangshan Public Security Bureau worth about RMB 9 million (£0.9 million). The contract is to provide networked surveillance services and solutions at approximately 300 Police Stations and 15 Police Security Bureaus in Tangshan City. This is BlueStar's first networking project with a municipal Public Security Bureau. Once the project has been successfully completed, BlueStar management believes it can be replicated in other cities across China according to the requirement by The Ministry of Public Security of China.Drug delivery and device technologies firm Consort Medical saw pre-tax profit fall 13% to £10.5m on revenue that fell to £118.6m from £120.3m before.The group said the results were due to the group facing destocking across its markets during the year, a material price reduction in one of Bespak's key contracts and a weak hospital market in the US for King Systems. Final dividend was maintained at 12.1p per share.Marketing services company Work Group said Rose Colledge will be appointed group chief executive with effect from June 21st, while finance director Michael Warren has decided to step down with effect from July 31st. "We have maintained our broad spread of clients and only 10 per cent of our income is derived from public sector organisations. Consequently we see no reason why expectations for the current year will not be met," said the group.Biopharmaceutical tiddler Valirx said it has now completed the first year of a two year Eurostars grant programme in which all developmental milestones have been met.
More News
26 Jul 2016 09:43

ValiRx Issues Shares To Bracknor For Loan Note Conversion (ALLISS)

Read more
14 Jul 2016 08:50

ValiRx Receives Approval To Submit Application For Cancer Drug Trial

Read more
7 Jul 2016 07:50

ValiRx Sells TRAC Technology To Germany's Sovicell For EUR800,000

Read more
13 Jun 2016 15:02

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jun 2016 09:19

ValiRx Highlights Progress With VAL201 Lead Compound, VAL401 Venture

Read more
19 May 2016 15:44

ValiRx updates market on 'significant' 2015

(ShareCast News) - Lifesciences company ValiRx reported on a "significant year" on Thursday, talking up its capital restructure and technical advancements in the 2015 calendar year. The AIM-traded firm, which focuses on cancer therapeutics and diagnostics for personalised medicine, said its Phase I/

Read more
19 May 2016 10:29

ValiRx Loss Narrows As Progress Is Made On Cancer Compounds

Read more
19 May 2016 09:23

ValiRx Says ValiSeek Begins Manufacturing VAL401 For Clinical Trial

Read more
29 Apr 2016 07:50

ValiRx Says ValiSeek Gets US Patent For VAL401 In Adenocarcinoma

Read more
19 Apr 2016 14:45

ValiRx Shares Fall After Bracknor Converts GBP200,000 Of Loan Notes (ALLISS)

Read more
1 Apr 2016 14:28

ValiRx Receives Conversion Notice For GBP90,000 From Bracknor (ALLISS)

Read more
21 Mar 2016 08:29

ValiRx Strikes GBP4 Million Convertible Funding Deal With Bracknor (ALLISS)

Read more
17 Mar 2016 09:07

ValiRx Hires Consultancy Firm Burns McClellan To Boost US Profile

Read more
17 Feb 2016 13:04

ValiRx Raises Funds To Back Ongoing Drug Trials (ALLISS)

Read more
16 Feb 2016 13:17

ValiRx achieves success in latest VAL201 trial

(ShareCast News) - ValiRx was pressing ahead with the trial process for its VAL201 trial treatment on Tuesday, following positive results from the most recent tranche of test patients. The AIM-traded life science company, with a focus on cancer diagnostics and therapeutics for personalised medicine,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.